Dietary patterns are associated with prevalence of fatty liver disease in adults

European Journal of Clinical Nutrition

Volumn 69, Issue 8, 2015, Pages 914-921

  Jia, Q ^a   Xia, Y ^a   Zhang, Q ^a   Wu, H ^a   Du, H ^a   Liu, L ^a   Wang, C ^a   Shi, H ^a   Guo, X ^a   Liu, X ^a   Li, C ^a   Sun, S ^a   Wang, X ^a   Zhao, H ^a   Song, K ^a   Huang, G ^a   Wu, Y ^a   Cui, N ^b   Niu, K ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN NANKAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEVERAGE; CARBOHYDRATE DIET; CHINA; CHOLESTEROL DIET; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET; DISEASE ASSOCIATION; FAST FOOD; FATTY LIVER; FEMALE; FRUIT; HUMAN; MALE; NONALCOHOLIC FATTY LIVER; PROTEIN DIET; SEX DIFFERENCE; VEGETABLE; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANALYSIS; EATING; FACTORIAL ANALYSIS; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROCEDURES; PROSPECTIVE STUDY; PROTEIN INTAKE; STATISTICS AND NUMERICAL DATA;

CARBOHYDRATE DIET; PROTEIN INTAKE;

ADULT; CHINA; CROSS-SECTIONAL STUDIES; DIET; DIET SURVEYS; DIETARY CARBOHYDRATES; DIETARY PROTEINS; EATING; FACTOR ANALYSIS, STATISTICAL; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 84938957956     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.297     Document Type: Article

References (30)

1. Angulo P.. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007; 25: 883-889
2. Jaurigue MM, Cappell MS. Therapy for alcoholic liver disease. World J Gastroenterol 2014; 20: 2143-2158
3. Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol 2013; 28 (Suppl 1): 11-17
4. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393
5. Cheung O, Sanyal AJ. Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol 2009; 25: 230-237
6. Bellentani S, Dalle Grave R, Suppini A, Marchesini G, Fatty Liver Italian N. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology 2008; 47: 746-754
7. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z et al. Long term nutritional intake and the risk for non-Alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 2007; 47: 711-717
8. Di Minno MN, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, Tarantino G. Omega-3 fatty acids for the treatment of non-Alcoholic fatty liver disease. World J Gastroenterol 2012; 18: 5839-5847
9. Petit JM, Guiu B, Duvillard L, Jooste V, Brindisi MC, Athias A et al. Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes. Clin Nutr 2012; 31: 520-525
10. Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 2002; 13: 3-9
11. Oddy WH, Herbison CE, Jacoby P, Ambrosini GL, O'Sullivan TA, Ayonrinde OT et al. The Western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence. Am J Gastroenterol 2013; 108: 778-785
12. Sun S, Wu H, Zhang Q, Wang C, Guo Y, Du H et al. Subnormal peripheral blood leukocyte counts are related to the lowest prevalence and incidence of metabolic syndrome: Tianjin chronic low-grade systemic inflammation and health cohort study. Mediators Inflamm 2014; 2014: 412386
13. Song K, Du H, Zhang Q, Wang C, Guo Y, Wu H et al. Serum immunoglobulin M concentration is positively related to metabolic syndrome in an adult population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) Cohort Study. PLoS One 2014; 9: e88701
14. Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Digest Dis 2008; 9: 108-112
15. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr 2007; 85: 910-918
16. Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y et al. Dietary habits and nutrient intake in non-Alcoholic steatohepatitis. Nutrition 2007; 23: 46-52
17. Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 2008; 22: 811-816
18. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-Aged women. JAMA 2004; 292: 927-934
19. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009; 51: 918-924
20. Miele L, Dall'armi V, Cefalo C, Nedovic B, Arzani D, Amore R et al. A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-Alcoholic fatty liver disease. Genes Nutr 2014; 9: 383
21. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nature reviews. Gastroenterol Hepatol 2010; 7: 251-264
22. Shi L, Liu ZW, Li Y, Gong C, Zhang H, Song LJ et al. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci 2012; 25: 383-391
23. Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-Alcoholic fatty liver disease (NAFLD). J Hepatol 2012; 57: 384-391
24. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 2002; 287: 2559-2562
25. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Int Med 2004; 140: 211-219
26. Day CP. Genes or environment to determine alcoholic liver disease and nonalcoholic fatty liver disease. Liver Int 2006; 26: 1021-1028
27. Rotily M, Durbec JP, Berthezene P, Sarles H. Diet and alcohol in liver cirrhosis: a case-control study. Eur J Clin Nutr 1990; 44: 595-603
28. Naveau S, Dobrin AS, Balian A, Njike-Nakseu M, Nohra P, Asnacios A et al. Body fat distribution and risk factors for fibrosis in patients with alcoholic liver disease. Alcohol Clin Exp Res 2013; 37: 332-338
29. Sid B, Verrax J, Calderon PB. Role of oxidative stress in the pathogenesis of alcohol-induced liver disease. Free Radic Res 2013; 47: 894-904
30. Sid B, Verrax J, Calderon PB. Role of AMPK activation in oxidative cell damage: implications for alcohol-induced liver disease. Biochem Pharmacol 2013; 86: 200-209